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Abstract
Precise regulation of MHC class II expression plays a crucial role in the control of the immune
response. The transactivator CIITA behaves as a master controller of constitutive and inducible
MHC class II gene activation, but its exact mechanism of action is not known. Activation of MHC
class II promoters requires binding of at least three distinct multi-protein complexes (RFX, X2BP
and NF-Y). It is known that the stability of this binding results from cooperative interactions
between these proteins. We show here that expression of CIITA in MHC class II– cells triggers
occupation of the promoters by these complexes. This observation raised the possibility that the
effect of CIITA on promoter occupation is mediated by an effect on the cooperative stabilization of
the DNA-bound multi-protein complexes. We show, however, that the presence of CIITA does not
affect the stability of the higher-order protein complex formed on DNA by RFX, X2BP and NF-Y.
This suggests other mechanisms for CIITA-induced promoter occupancy, such as an effect on
chromatin structure leading to increased accessibility of MHC class II promoters. This ability of
CIITA to facilitate promoter occupation is undissociable from its transactivation potential. Finally,
we conclude that this effect of CIITA is cell-type specific, since expression of CIITA is not required
for normal occupation of MHC class II promoters in B lymphocytes.
Introduction
MHC class II molecules are heterodimeric cell surface proteins
implicated in at least three crucial processes of the immune
response (1). First, they initiate and sustain antigen-specific
immune responses by presenting antigenic peptides to the
receptor of CD41 Th lymphocytes. MHC class II expression
is also an absolute requirement for superantigen-induced T
cell activation. Second, they shape the T cell repertoire by
directing positive and negative selection events in the thymus.
Finally, they also participate in activation of the antigen-
presenting cells (APC) on which they are expressed. In
contrast to the relatively ubiquitous cell type distribution of
MHC class I molecules, constitutive MHC class II expression
is largely restricted to highly specialized APC such as dendritic
cells, B lymphocytes and macrophages. In addition, MHC
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class II genes can be induced in many other cell types, in
particular by IFN-γ.
Both the constitutive and inducible modes of MHC class II
expression are regulated at the level of transcription by a
short promoter proximal enhancer containing four highly
conserved cis-acting DNA sequences referred to as the S,
X, X2 and Y boxes (2). Most of what is currently known about
the molecular mechanisms controlling MHC class II gene
transcription via these cis-acting DNA sequences has come
from studies of genetic defects in MHC class II regulation, in
particular from patients having a rare genetic disease called
MHC class II deficiency (2–5). Elucidation of the genetic
defects underlying this disease has allowed us to clone four
transcription factors (CIITA, RFX5, RFXANK and RFXAP)
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directly implicated in MHC class II gene regulation. RFX5,
RFXANK and RFXAP are three subunits of RFX, a ubiquitously
expressed multimeric DNA-binding complex that binds spe-
cifically to the X box of MHC class II promoters (3,6–8). In
contrast to RFX, CIITA is a non-DNA binding transactivator
characterized by a highly regulated pattern of cell type-
specific and inducible expression. It is the differential expres-
sion of CIITA that controls the constitutive and inducible
pattern of MHC class II gene transcription (9,10). Interestingly,
the complex control of CIITA expression is achieved by the
differential activation of multiple alternative promoters (11).
The RFX complex interacts cooperatively with two other
transcription factors, X2BP (12,13) and NF-Y (14), such that
binding of all three complexes to MHC class II promoters is
strongly stabilized (13,15–18). The formation of these stable
higher-order protein–DNA complexes is essential for in vivo
occupation and activation of MHC class II promoters. In
contrast to RFX, CIITA is believed to be recruited to the MHC
class II promoter by protein–protein interactions with DNA
bound factors such as RFX5 and is thought to activate
transcription by contacting the basal transcription machinery
via an N-terminal activation domain (19–23). On the other
hand, CIITA was until now not thought to be involved in
promoter occupation, because MHC class II promoters are
occupied normally (24,25) in B cell lines in which the CIITA
gene is severely mutated (9,26)
Here, we have analyzed the dependence of MHC class II
promoter occupancy on CIITA, and examined the effect of
CIITA on cooperative binding between RFX, X2BP and NF-Y
in two different situations; constitutive MHC class II expression
in B cells and induced expression in MHC class II– cells
transfected with CIITA or stimulated with IFN-γ. In contrast to
what was previously believed, the results demonstrate that
CIITA indeed plays a key role in promoter occupancy, but
that this is only evident in certain cell types. While CIITA is
dispensable for constitutive promoter occupancy in B cells,
it is clearly required for promoter occupancy induced in
fibroblasts and other MHC class II– cells by IFN-γ (27,28) or
by transfection with CIITA (29 and this study). Since MHC
class II promoter occupation is known to be dependent on
the cooperative assembly of a strongly stabilized multi-protein
complex containing RFX, X2BP and NF-Y (13,15–18), it
seemed likely that this CIITA-induced promoter occupation
could be due to a direct effect on the stability of this complex.
Surprisingly, our results reveal that CIITA-induced promoter
occupancy is not the result of an effect of CIITA on the
stabilization resulting from cooperative binding between RFX,
X2BP and NF-Y. Indeed, both the concentrations of these
DNA binding proteins in nuclear extracts and the stability of
the higher-order complexes they can form on the MHC class
II promoter are independent of the presence of CIITA. These
results suggest that CIITA facilitates in vivo occupation of
MHC class II promoters indirectly by affecting the accessibility
of the promoter DNA rather than directly by affecting the
concentration or binding affinity of the multi-protein RFX–
X2BP–NF-Y complex.
Methods
Cell culture and transfections
The B lymphoblastoid cell line Raji, its CIITA-deficient variant
RJ2.2.5, the human melanoma cell line GL 19, GL 19 trans-
fected with CIITA, the monocytic cell line C119/9 [subclone
derived from U937 (30)] and C119/9 transfected with CIITA
were grown in RPMI 1640. HeLa cells and HeLa transfected
with CIITA were grown in DMEM. Both media were supple-
mented with glutamine, 10% heat-inactivated FCS and anti-
biotics. Cells were incubated at 37°C in 5% CO2. For
induction of MHC class II expression, cells were incubated
for 48–72 h with 500 U/ml of recombinant human IFN-γ. GL
19 melanoma cells were transfected as described using
calcium phosphate precipitation followed 4 h later by a
glycerol shock (31). C119/9 cells (30) (13107 cells) were
washed in cold PBS, resuspended in 0.5 ml PBS containing
10 µg of linearized CIITA plasmid and transfected by electro-
poration with a BioRad electropulser using a 300 V/960 µF
pulse. After selection with hygromicin HLA class II1 cells
were selected with Dynabeads. HeLa cells were transfected
as above by electroporation with a 250 V/960 µF pulse. Stably
transfected cells were isolated after selection with hygromicin
for 15 days and analyzed for MHC class II expression
by FACS (polymorphic HLA-DR mAb 2.06) as previously
described (9). Plasmids used for transfections were the empty
EBO-Sfi expression vector, EBO-Sfi containing a full-length
CIITA cDNA (9), EBO-sfi containing the mutated CIITA-allele
2 of patient BCH (32), EBO-sfi containing the mutated CIITA-
gene of patient BLS-2 (9) and EBO-sfi containing the dominant
negative NLS-D5 form of CIITA (33).
In vivo footprint analysis
In vivo footprint experiments were performed as described
previously (34) using Vent DNA polymerase (New England
Biolabs, Beverley, MA) for all steps of the ligation-mediated
PCR reaction (LM-PCR). The sequences of the oligonucleo-
tides and the incubation temperatures used for the LM-PCR
reactions were as described (34).
Electrophoretic mobility shift assays (EMSA)
Nuclear extracts were prepared from 2–83108 cells as
described (15,16). The DRA-XY (–150 to –59 bp), DRA-XX2
(–144 to –70 bp) and DRA-Y (–89 to –49 bp) oligonucleotide
probes (Fig. 1) were prepared as described (35). With the
exception of the following modifications, EMSA experiments
were performed essentially as described (15,16). Experiments
were performed at room temperature for binding of NF-Y, RFX
1 NF-Y, RFX 1 X2BP and RFX 1 NF-Y 1 X2BP or on ice for
binding of RFX. Binding mixtures were pre-incubated for 30
min prior to addition of 40,000 c.p.m. of the suitable 32P-
labeled oligonucleotide probes. Probes used were DRA-XX2
for binding of RFX and RFX 1 X2BP, DRA-Y for binding of
NF-Y, and DRA-XY for binding of RFX 1 NF-Y and RFX 1
X2BP 1 NF-Y. Reactions were then incubated for a further 45
min to allow binding to proceed to completion, after which
they were supplemented with a 500-fold molar excess of
unlabeled probe and incubated for various times (Figs 4 and
5) prior to gel electrophoresis. Binding was done in 20 µl
reactions containing 8 µg of nuclear extract, 5 mM MgCl2, 50
µg of BSA, 0.01% NP-40, 10 ng of a methylated pBR322
oligonucleotide (see 15,16) and the following competitor
DNAs. Amounts of added poly(dI–dC)·poly(dI–dC) and
sonicated denatured Escherichia coli DNA were respectively
1 and 0.5 µg for NF-Y, 0.8 and 0.4 µg for RFX, 0.6 and 0.3
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Fig. 1. Schematic representation of the HLA-DRA promoter. The S, X, X2 and Y boxes are present in all MHC class II promoters, and are
crucial cis-acting regulatory sequences controlling transcription of MHC class II genes. T represents the TATA box. The octamer sequence
(O) is present in the HLA-DRA promoter but not in other MHC class II genes. The DRA-XY, DRA-XX2 and DRA-Y oligonucleotides used in
EMSA experiments are shown below. The RFX complex binding to the X box is composed of three subunits (RFX5, RFXANK and RFXAP)
(4,6–8). NF-Y and X2BP are nuclear proteins that bind to the Y and X2 boxes respectively. CIITA is believed to be recruited to MHC class II
promoters by protein–protein interactions with one or more of the DNA bound factors.
µg for RFX 1 X2BP, 1 and 0.5 µg for RFX 1 NF-Y, and 0.5
and 0.25 µg for RFX 1 NF-Y 1 X2BP. An aliquot of 50 ng of
an X2 box competitor oligonucleotide was also included for
binding of RFX and RFX 1 NF-Y.
Results
Induction of CIITA expression in MHC class II– cells leads to
the occupation of MHC class II promoters
In vivo footprint experiments were performed to analyze
promoter occupation. The promoter is occupied constitutively
in the MHC class II1 B cell line Raji (Fig. 2, lanes 15 and 16).
Protections are particularly clear at the guanosine residues
–104 in the X box, –98 and –93 in the X2 box, –71, –68, and
–67 in the Y box, and –53 and –48 in the octamer sequence.
This pattern is identical to what has been described previously
(24). In RJ2.2.5, a CIITA-deficient and MHC class II– variant
derived from Raji, the promoter is also occupied normally
(Fig. 2, lanes 13 and 14). The same has been observed in
other CIITA-deficient B cell lines (24,25). Clearly, therefore,
promoter occupation in B cells is not dependent on CIITA. It
is also not dependent on transcriptional activity because the
MHC class II genes are not expressed in these CIITA-deficient
B cells.
The situation is very different for cell types in which expres-
sion of MHC class II genes is induced by stimuli such as IFN-
γ. The promoter is bare in the uninduced human melanoma
cell line GL 19 (Fig. 2, lanes 1 and 2) and the monocytic cell
line C119/9 (Fig. 2, lanes 9 and 10). Two approaches for
studying the effect of CIITA on promoter occupancy in these
cells were explored; induction with IFN-γ and transfection with
a CIITA expression vector. Induction of MHC class II gene
expression in GL 19 by treatment with IFN-γ is accompanied
by the appearance of an occupied promoter (Fig. 2, lanes 3
and 4). As judged by the pattern of protected G residues,
occupation of the X, X2 and Y boxes in the induced GL 19
cells is identical to that observed in Raji B cells. As described
previously (27) occupation of the octamer sequence is less
evident in the induced cells than in B cells. Similar results
have been observed for other IFN-γ inducible cell lines,
including HeLa (27,28).
De novo expression of CIITA is an obligatory intermediate
step in the signal transduction pathway leading to the induc-
tion of MHC class II genes by IFN-γ. To determine whether
the induction of promoter occupation by IFN-γ is a direct
consequence of CIITA expression, uninduced GL 19 cells
were transfected with a CIITA expression vector. Cells trans-
fected with empty expression vector were used as controls.
The results demonstrate that transfection with CIITA is suffi-
cient to obtain normal promoter occupancy (Fig. 2, lanes 7
and 8) and activate expression of MHC class II genes. The
pattern of protected G residues observed in the CIITA-
transfected cells is identical to that observed in the IFN-γ-
induced cells (Fig. 2, lanes 3 and 4). The same results are
observed in the monocytic cell line C119/9, where transfection
with CIITA also induced an occupied promoter (Fig. 2, lanes
11 and 12). In contrast to what is observed in B cells, these
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Fig. 2. In vivo footprint analysis of the HLA-DRA promoter in cells lacking or expressing CIITA. In vivo footprint analysis was performed with
uninduced GL 19 cells (lanes 1 and 2), GL 19 cells induced with IFN-γ (lanes 3 and 4), GL 19 cells transfected with an empty expression
vector (stuffer, lanes 5 and 6), GL 19 cells transfected with a CIITA expression vector (lanes 7 and 8), C119/9 monocytic cells transfected with
an empty vector (lanes 9 and 10), C119/9 transfected with CIITA (lanes 11 and 12), RJ2.2.5 cells (lanes 13 and 14) and Raji cells (lanes 15
and 16). Lanes 2, 4, 6, 8, 10, 12, 14 and 16: the cells were treated with DMS, the DNA was purified and cleaved at methylated nucleotides
with piperidine, and cleaved fragments spanning the DRA promoter were amplified by LM-PCR and analyzed by sequencing gel electrophoresis.
Lanes 1, 3, 5, 7, 9, 11, 13 and 15: control samples representing unoccupied DNA were obtained by performing the procedure with naked
DNA purified from the same cells. Positions of the X, X2, Y and O cis-acting sequences, and the protected positions observed in IFN-γ-treated
GL 19 cells (lane 4), GL 19 cells transfected with CIITA (lane 8), C119/9 cells transfected with CIITA (lane 12), RJ2.2.5 (lane 14) and Raji (lane
16) are indicated.
results demonstrate that in other cells types, occupation of
MHC class II promoters requires CIITA. MHC class II promoter
occupancy thus exhibits a cell type-dependent requirement
for CIITA.
The ability of CIITA to induce promoter occupation is undisso-
ciable from its transactivation potential
The ability of CIITA to activate transcription of MHC class II
genes relies on two different functions that map to two different
regions of the protein. The N-terminal region of CIITA contains
a transcription activation domain that is believed to contact
the basal transcription machinery (19–23). The C-terminus of
CIITA, on the other hand, is believed to mediate protein–
protein interactions required for recruitment to the MHC
class II promoter (20–22). To determine whether promoter
occupation induced by CIITA could be attributed to one or
both of these functional domains we analyzed three different
mutants of CIITA. In B cell lines from patients having mutations
in the CIITA gene (BLS-2 and BCH) MHC class II promoters are
normally occupied even though the genes are transcriptionally
silent. It therefore seemed possible that the mutated forms of
CIITA of these patients could retain the capacity to drive
occupation of the promoter. In both patients, CIITA is disrupted
by a small deletion in the C-terminal part of the gene (Fig.
3A). The NLS-D5 mutant of CIITA has been demonstrated to
function as a dominant negative molecule (Fig. 3B) (33). This
mutant has a deletion of the N-terminal part of the gene and
has lost the activation domain of CIITA (3,20,21,33). On the
other hand, NLS-D5 retains intact the C-terminal region of
CIITA that is believed to be required for its recruitment to
MHC class II promoters (20,21). We therefore thought that
the capacity to induce promoter occupation might be main-
tained by this mutant. To determine whether the NLS-D5, BCH
and BLS-2 versions retained the ability to induce promoter
occupation, they were transfected into HeLa cells. These
three mutated forms of CIITA are unable to activate expression
of MHC class II genes (Fig. 3B). In addition NLS-D5 has a
strong dominant negative effect that severely hinders induc-
tion of MHC class II expression by IFN-γ (Fig. 3B). Promoter
occupation could not be observed in any of the three transfec-
tants, while promoter occupation could be induced normally
by transfection with wild-type CIITA (Fig. 3C). These results
suggest that the transactivation activity of CIITA is undissoci-
able from its ability to induce the occupation of MHC class II
promoters and requires the same functional domains. The
same conclusion has recently been arrived at by another
study using a different series of CIITA mutants (29).
Stability of the complexes bound to MHC class II promoters
is independent of CIITA
Previous in vitro binding studies have demonstrated that RFX
binds cooperatively with two other MHC class II promoter
binding proteins, X2BP and NF-Y (13,15–18). These
cooperative binding interactions strongly enhance the stability
with which RFX, X2BP and NF-Y are bound to their respective
X, X2 and Y box target sites. The strongly stabilized binding
observed in the higher order RFX 1 X2BP 1 NF-Y complex
is essential for promoter occupation in vivo. Indeed, in cell
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Fig. 3. In vivo footprint analysis of the HLA-DRA promoter in HeLa
cells expressing mutated CIITA proteins. (A) Schematic view of CIITA
and the different mutants analyzed. Mutant BCH (allele 2) has a
deletion of 27 amino acids in the C-terminus (∆ 1079–1106). Mutant
BLS-2 has a deletion of 23 amino acids in the C-terminus (∆
940–963). The dominant-negative NLS-D5 mutant has a nuclear
localization signal (NLS) at its N-terminus and has a deletion of the
first 294 amino acids. A, acidic region; P/S/T, Pro/Ser/Thr-rich regions;
A/G, ATP/GTP-binding motif. (B) Cell surface expression of HLA-DR
in HeLa cells transfected with the mutated CIITA constructs. Black
profiles: cells transfected with the wild-type or mutated forms of
CIITA. Open profiles: cells transfected with empty expression vector.
To demonstrated the dominant negative effect of NLS-D5, the NLS-
D5 (black profile) and empty vector transfected cells (gray profile)
were treated with IFN-γ to induce MHC class II expression. (C) In
vivo footprint analysis was performed as outlined in Fig. 2 with Raji
cells (lane 1) and HeLa cells transfected with empty vector (lanes 2
and 3), wild-type CIITA (lane 4), the BCH mutant (lane 5), the BLS-2
mutant (lane 6) and the NLS-D5 mutant (lane 7). In the case of the
empty vector transfected samples, DMS treatment was done directly
with the cells (lane 3, in vivo) or with the purified DNA (lane 2, in vitro).
Positions that are protected in Raji (lane 1) and wild-type CIITA-
transfected cells (lane 4), but not in the other transfectants (lanes 3
and 5–7) are indicated at the right.
lines deficient in RFX the formation of these higher-order
complexes is abolished and the entire promoter remains bare
(16,17,25).
Considering this key role of cooperative binding in MHC
class II promoter occupancy and the fact that CIITA expression
can trigger promoter occupancy, it was logical to explore if
Fig. 4. Dissociation rate experiments performed with extracts from
HeLa and HeLa transfected with CIITA. Reactions optimized for
binding of RFX or NF-Y on their own, or for the simultaneous binding
of RFX 1 X2BP, RFX 1 NF-Y and RFX 1 X2BP 1 NF-Y (see Methods),
were first incubated to allow binding to proceed to completion, and
were then supplemented with an excess of unlabeled competitor
DNA and continued for 0, 5, 10, 30, 60 or 120 min prior to gel
electrophoresis. Nuclear extracts were from HeLa or HeLa transfected
with CIITA. The experiment for RFX was done on ice in order to
prolong the half-life of the RFX-DNA complex, which is ,5 min at
room temperature (15). All other experiments were performed at room
temperature. Only the regions of the gels containing the protein–DNA
complexes are shown.
Fig. 5. Dissociation rate experiments performed with extracts from
Raji and RJ2.2.5. Dissociation rate experiments with nuclear extracts
from Raji and RJ2.2.5 were done as described in Fig. 4.
the effect of CIITA was mediated by either an increase in the
concentration of RFX, X2BP or NF-Y, or by an enhanced
stability in the interactions between these proteins and their
target sites. The abundance and stability of various different
protein–DNA complexes were therefore analyzed by EMSA
experiments. As an indication of stability, the off-rates of the
protein–DNA complexes were examined. Four different cell
types were included in the analysis (Figs 4–6). Two of these
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Fig. 6. Quantification of the dissociation rate experiments. The gels shown in Figs 4 and 5 were quantified by PhosphorImager analysis. The
percent of the remaining protein–DNA complexes is plotted as a function of time. The amount of complex bound at time zero (addition of
unlabeled competitor DNA) was taken as 100%.
lack CIITA (HeLa and RJ2.2.5) while the other two express
CIITA (HeLa cells transfected with CIITA and Raji). For each
cell type, off-rates were determined for complexes containing
only RFX or NF-Y, and for the higher-order complexes con-
taining RFX 1 NF-Y, RFX 1 X2BP and RFX 1 X2BP 1 NF-Y. The
off-rate for X2BP bound on its own could not be determined
because its affinity for the X2 box in the absence of the other
two proteins is too low to permit detection of a stable complex
in EMSA experiments (15). Representative gels for HeLa and
HeLa transfected with CIITA are shown in Fig. 4, those for
Raji and RJ2.2.5 are shown in Fig. 5, and quantifications of
the results are shown in Fig. 6. Identical results were also
obtained in experiments comparing RJ2.2.5 with CIITA-trans-
fected RJ2.2.5 and uninduced HeLa with IFN-γ-treated HeLa
(data not shown). Four major conclusions can be drawn from
the data shown here. First, expression of CIITA does not
change the levels of RFX, X2BP and NF-Y detectable in the
nuclear extracts. This holds true both for B cells (Raji) and
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HeLa. Second, as observed previously (13,15,16), in all cell
types the interaction of RFX, X2BP and NF-Y with the promoter
is strongly stabilized in the higher-order RFX 1 X2BP, RFX 1
NF-Y and RFX 1 X2BP 1 NF-Y complexes. Third, there are
no significant differences between B cells (Raji and RJ2.2.5)
and HeLa cells (transfected or not with CIITA) with respect to
the stability of any of the different complexes. Fourth, no
differences in off-rates are observed between cells that lack
CIITA (uninduced HeLa and RJ2.2.5) and those that express
it (Raji and HeLa transfected with CIITA), indicating that CIITA
does not influence the stability of any of the complexes. Taken
together these results demonstrate that the effect of CIITA on
promoter occupancy is not mediated by an increase in
the expression levels of RFX, X2BP and NF-Y, or by an
enhancement in the efficiency with which these proteins can
form stable higher-order complexes on the promoter.
Discussion
A combination of biochemical and genetic evidence has
formally demonstrated that the DNA binding complex RFX
and the non-DNA binding transactivator CIITA are both key
components of the molecular machinery that controls the
activity of the MHC class II promoters (3,4,36,37). Although
both are essential for MHC class II expression, their respective
modes of action are believed to be quite different. RFX binds
cooperatively with two other MHC class II promoter binding
proteins, X2BP (12,13) and NF-Y (14), to generate a very
stable higher-order protein–DNA complex and this stable
binding is required for promoter activation (13,15–18). Forma-
tion of this higher-order complex is clearly required for occupa-
tion of MHC class II promoters in vivo, because these
promoters remain bare (24,25) in cells in which formation of
the higher-order complex is abrogated by mutations des-
troying RFX (3,6) or by mutations in the Y box of MHC class
II promoters (38). In the case of CIITA, existing evidence
suggests that it is recruited to the promoter by protein–protein
interactions with one or more DNA bound factors such as the
RFX5 subunit of RFX and that it activates transcription by
contacting components of the basal transcription machinery
via an acidic activation domain (19–22). In contrast to RFX,
CIITA has been believed to be dispensable for promoter
occupation in vivo because occupancy remains essentially
normal in mutant B cell lines lacking functional CIITA (24,25).
However, we now demonstrate here that CIITA does in fact
also play a role in promoting promoter occupation, but that
this is not evident in all cell types: while CIITA is not necessary
for promoter occupation in B cells, it is required in cell types
in which MHC class II expression depends on induction with
stimuli such as IFN-γ (Fig. 2). This is consistent with similar
results presented in another recent study using cell types
distinct from those used here (29). The analysis of different
mutants of CIITA suggests that the transactivation potential
of CIITA and its ability to influence promoter occupation
map to the same functional domains of the protein (Fig.
3). Moreover, we demonstrate that CIITA affects promoter
occupation by a mechanism that is distinct from the stabiliza-
tion that results from the cooperative binding between RFX,
X2BP and NF-Y (Figs 4–6).
Two different MHC class II promoter occupancy phenotypes
can be observed in cells lacking CIITA (Fig. 2). Promoter
occupancy is normal in B lymphoblastoid cells such as
RJ2.2.5 which lack functional CIITA (Fig. 2). On the other
hand, the promoter is bare in CIITA– cells such as uninduced
GL 19 melanoma cells, C119/9 monocytic cells and HeLa
cells (Figs 2 and 3) (24,25,27,28). This cannot be explained
by a difference in the expression levels of proteins known to
be required for occupation, i.e. RFX, X2BP and NF-Y (Figs 4
and 5). Surprisingly, it is also not the result of differences in the
stability of the higher-order protein–DNA complexes formed by
cooperative binding between these three proteins (Figs 4–6).
It can also be excluded that promoter occupancy simply
reflects active transcription, because neither mutant B cells
lacking CIITA (RJ2.2.5) nor the uninduced melanoma cells,
monocytes and HeLa cells express MHC class II genes.
Consequently, it is likely that the difference in promoter
occupancy observed between these two MHC class II– cell
types reflects a difference in the accessibility of the DNA
within the chromatin structure at the promoter.
A difference in promoter accessibility is not observed only
when comparing B cells and MHC class II– cells. Changes in
promoter accessibility also appear to occur during differenti-
ation within the B cell lineage. Developmental extinction of
MHC class II expression in plasmocytes is accompanied by
the appearance of a bare promoter phenotype that can be
reversed by transfection with CIITA (34 and data not shown).
As described here for IFN-γ inducible cells, the bare promoter
in plasmocytes is not a consequence of the absence of RFX,
X2BP or NF-Y, or of a reduced ability to form stable higher-
order protein–DNA complexes (34). Compared to MHC class
II– B cells, plasmocytes thus seem to acquire a tighter
chromatin structure prohibiting occupation of MHC class II
promoters by RFX, X2BP and NF-Y.
Transfection with CIITA is sufficient to overcome the access-
ibility barrier opposing binding of RFX, X2BP and NF-Y in vivo
to the MHC class II promoter in MHC class II– cells. How
CIITA achieves this remains a matter of speculation. Several
possibilities come to mind. One possibility is that interaction
of CIITA with RFX, X2BP and/or NF-Y contributes an additional
stabilizing effect that is not detectable by in vitro binding
assays. It is also possible that this interaction induces a
conformational change in the RFX–X2BP–NF-Y complex that
is required to maintain stable binding of these proteins in vivo.
Alternatively, perhaps CIITA facilitates access of the DNA
binding proteins to the DNA because it has a direct or indirect
effect on the chromatin structure at the promoter: it could, for
example, recruit chromatin remodeling factors such as histone
acetylases (39,40) or the Swi/Snf complex (41,42). Clearly,
the precise mode of action of CIITA is far from elucidated
and the novel observations made here point to several
potential mechanisms that need to be explored.
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Abbreviations
APC antigen-presenting cell
EMSA electrophoretic mobility shift assay
LM-PCR limited-mobility polymerase chain reaction
NLS nuclear localization signal
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